Skip to main content

Localization of Radioiodinated Estrogenic Stilbenes in Normal and Neoplastic Rat Prostate

  • Chapter
Progress in Radiopharmacology 3

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 2))

  • 35 Accesses

Abstract

Carcinoma of the prostate is primarily a disease of old age, rarely occurring before the age of 50 but with increasing frequency with advancing age (1,2). In general this malignancy has a slow growth rate and as a result, the more aggresive and radical therapy, which would be justifiable in younger patients and in other diseases, has to be balanced against the potential improvement in both quality and quantity of life (3).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mostofic F, Leestma J, Lower urinary tract and male genitalia. In: Pathology, Vol. I, 6th ed. Anderson W (ed), Mosby, St. Louis, p. 850, 1971.

    Google Scholar 

  2. Whitemore WF, jr, The natural history of prostatic cancer. Cancer 32: 1104, 1973.

    Article  Google Scholar 

  3. Corriere JN, jr, Cornog JL, Murphy JJ, Prognosis in patients with carcinoma of the prostate. Cancer 25: 911, 1970.

    Article  PubMed  Google Scholar 

  4. Gleason DF, Histologic grading and clinical staging or prostatic cancer. In: Urologic Pathology: The prostate. Tannenbaum M (ed), Lea & Febiger, Philadelphia, p. 171, 1977.

    Google Scholar 

  5. McGowan DG, unpublished.

    Google Scholar 

  6. Bruchovsky N, Rennie P, Van Doorn E, Steroid receptors in cancer. Mod. Med. of Canada 31: 914, 1976.

    CAS  Google Scholar 

  7. DeSombre ER, Smith S, Block GE et al. Prediction of breast cancer response to endocrine therapy. Cancer Chemother. Rep. 58: 513, 1974.

    CAS  Google Scholar 

  8. Krohn KA, The search for a gamma-emitting estrogenic ligand. J. nucl. Med. 21: 593, 1980.

    PubMed  CAS  Google Scholar 

  9. Rivenson A, Silverman J, The prostatic carcinoma in laboratory animals. Invest. Urol. 16: 468, 1979.

    PubMed  CAS  Google Scholar 

  10. Tubis M, Endow JS, Bland WH, The preparation of 1311 labeled diethylstilbestrol diphosphate and its potential use in nuclear medicine. J. nucl. Med. 6: 184, 1967.

    CAS  Google Scholar 

  11. Mende T, Wollny G, Gens J, On the use of radioiodine-labeled diethylstilbestrol diphosphate as a scanning agent of the liver. Nucl. med. Comm. 3,1982 in press. See: Wollny G, Gens J, Mende T, Jahresbericht des Bereiches Kernchemis des ZFK Rossendorf, 340–60, 1977.

    Google Scholar 

  12. Flanagan RJ, Lently BC, McGowan DG, Wiebe LI, a-Halostilbenes related to diethylstilbestrol. J. rad. Chem. 65, 81, 1981.

    Article  CAS  Google Scholar 

  13. Ediss C, McQuarrie SA, In-house design and construction.

    Google Scholar 

  14. Ullberg S, Bengtsson G, Autoradiographic distribution studies with natural estrogens, Acta endocr. 43: 75, 1963.

    PubMed  CAS  Google Scholar 

  15. Eakins MN, Palmer AJ, Waters SL, Studies in the rat with 18F-4-fluoroestradiol and 18F-4-fluoro-oestrone as potential prostate scanning agents: comparison with 1251–2-iodo-oestradiol and 1251–2,4-diiodo-oestradiol. Int. J. appl. Radiat. Isotopes 30: 395, 1979.

    Google Scholar 

  16. McElvany KD, Katzenellebogen JA, Senderoff SG, Siegel BA, Welch MJ, Tissue distribution, clearance rates and radiation dosimetry of 16N(Br-77)-bromoestradiol-1713. J. nucl. Med. 22:19, 1981.

    Google Scholar 

  17. Gatley SJ, Shaughnessy WJ, Inhorn L, Lieberman LM, Studies with 17ß(167(125I) Iodo)-Estradiol, an estrogen receptor-binding radiopharmaceutical, in rats bearing mammary tumors. J. nucl. Med. 22: 459, 1981.

    PubMed  CAS  Google Scholar 

  18. Mazaitis JK, Gibson RE, Kornai T, Eckelman WC, Francis B, Reba RC, Radioiodinated estrogen derivatives, J. nucl. Med. 21: 142, 1980.

    PubMed  CAS  Google Scholar 

  19. Heiman DF, Senderoff SG, Katzenellebogen JA, Neeley RJ, Estrogen receptor based imaging agents. 1. Synthesis and receptor binding affinity of some aromatic and D-ring halogenated estrogens. J. med. Chem. 23: 994, 1980.

    Article  PubMed  CAS  Google Scholar 

  20. Dodds EC, Lawson W, Noble RL, Biological effects of the synthetic oestrogenic substance 4:4’-dihydroxy-a:diethylstilbene. Lancet 1: 1389, 1938.

    Article  Google Scholar 

  21. Grundy J, Artificial estrogens. Chem. Rev. 57: 281, 1957.

    Google Scholar 

  22. Kornai T, Eckelman WC, Johnsonbaugh RE, Mazaitis A, Kubota H, Reba RC, Estrogen derivatives for the external localization of estrogen-dependent malignancy. J. nucl. Med. 18: 360, 1977.

    Google Scholar 

  23. Marberger H, Riedesel RD, Anderson DO, Malek LB, A comparative study of phosphatase activities of various human tissues. J. Urol. 75: 857, 1956.

    PubMed  CAS  Google Scholar 

  24. Hawkins EF, Nijs M, Brassine C, Tagnon HJ, Steroid receptors in the human prostate. 1. Estradiol-17ß binding in human prostatic hypertrophy. Steroi 26: 458, 1975.

    Article  CAS  Google Scholar 

  25. Bashirelahi N, O’Toole JH, Young JD, A specific 1713-estradiol receptor in human benign hypertrophic prostate. Biochem. Med. 15: 254, 1976.

    Article  PubMed  CAS  Google Scholar 

  26. Eckman P, Snochowski M, Dahlberg E, Bression D, Hogberg B, Gustafsson JA, Steroid receptor content in cytosol from normal and hyperplastic human prostates. J. clin. Endocr. Metab. 49: 205, 1979.

    Article  Google Scholar 

  27. Fergusson JD, Castration and oestrogen therapy. In: Endocrine Therapy of malignant disease. Stoll BA (ed), Saunders, London, p. 247, 1972.

    Google Scholar 

  28. Noble RL, Hochachka B, King D, Spontaneous and estrogen produced tumors i Nb rats and their behavior after transplantation. Cancer Res. 35: 766, 197

    Google Scholar 

  29. Dunning WF, Prostatic cancer in the rat. Nat. Cancer Inst. Monograph, 12: 351, 1963.

    CAS  Google Scholar 

  30. Drago JR, Ikeda RM, Maurer RE, Goldman LB, Tesluk H, The Nb rat: prestati adenocarcinoma model. Invest. Urol. 16: 353, 1979.

    PubMed  CAS  Google Scholar 

  31. Seman G, Meyers B, Bowen JM, Dmochowski L, Histology and ultrastructure o the R-3327 C-F transplantable prostate tumor of Copenhagen-Fisher rats. Invest. Urol. 16: 231, 1978.

    PubMed  CAS  Google Scholar 

  32. Collins JM, Bagwell CB, Block NL, Claflin AJ, Orvin GL, Pollack A, Stover Flow cytometric monitoring of R3327 rat prostate carcinoma. Invest. Urol. 19: 8, 1981.

    PubMed  CAS  Google Scholar 

  33. Heston WDW, Menon M, Tananis C, Walsh PC, Androgen, estrogen and progesterone receptors of the R3327 Copenhagen rat prostatic tumor. Cancer Lett 6: 45, 1979.

    Article  PubMed  CAS  Google Scholar 

  34. Ip MM, Milholland RJ, Rosen F, Functionality of estrogen receptor and Tamoxifen treatment of R3327 Dunning rat prostatic adenocarcinoma. Cancer Res. 40:2188, 1980.

    Google Scholar 

  35. Mende T, Wollny G, Gens J, Schubert J, Verteilung und kinetik von Diaethy= stilbostroldiphosphat(Cytonol) nach intravenoeser injektion. Europ. J. nu(Med. 4:133, 1979.

    Google Scholar 

  36. Mende T, Hennig K, Wollny G, Gens J, Experimentelle untersuchungen über d_ Verteilung von intravenoes injiziertem jodmarkiertem Cytonol (diaethylsti1 bostroldiphosphat). Z. Urol. u. Nephrol. 71: 529, 1978.

    CAS  Google Scholar 

  37. Tesone M. Chazenbalk GD, Ballejos G, Charreau EH, Estrogen receptor in rat pancreatic islets. J. Steroid Biochem. 11: 1309, 1979.

    Article  PubMed  CAS  Google Scholar 

  38. Dahlberg E, Snochowki M, Gustafsson JA, Comparison of the R-3327H rat prostatic adenocarcinoma to human benign prostatic hyperplasia and metastatic carcinoma of the prostate with regard to steroid hormone receptors. The prostate, 1: 61, 1980.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Martinus Nijhoff Publishers, The Hague

About this chapter

Cite this chapter

Wiebe, L.I., Flanagan, R.J., Gati, L., Lentle, B.C., McGowan, D.G. (1982). Localization of Radioiodinated Estrogenic Stilbenes in Normal and Neoplastic Rat Prostate. In: Cox, P.H. (eds) Progress in Radiopharmacology 3. Developments in Nuclear Medicine, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-7669-6_16

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-7669-6_16

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-009-7671-9

  • Online ISBN: 978-94-009-7669-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics